Chinese Journal of New Drugs 2011 Issue 1 Pharmaceutical care of clinical pharmacist for patients with pulmonary embolism

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Chinese Journal of New Drugs
1003-3734
2011 Issue 1

Pharmaceutical care of clinical pharmacist for patients with pulmonary embolism
WANG Lai-Cheng;HAN Qiang;L Dong-Mei

..............page:83-86

zhong guo xin yao za zhi tou gao xu zhi

..............page:90-92

Real options in new drug investment’s evaluation
SUN Guo-jun;FENG Fang-qin;FAN Qiao-mei;YU Guo-tao;SHAN Wei-guang

..............page:10-13

Mechanism and the structure-activity relationship of umbelliferone and aesculetin with DNA
ZHANG Ai-ping;YANG Jin-yan;ZHENG Mao-dong;HAO Juan;HUANG Qian

..............page:68-74

Analysis on common defects in bioequivalence studies of drug registrations
ZHANG Yu-hu

..............page:14-17

xin xi

..............page:9,13,46,67,86,89

Treatment of adverse drug reactions of sorafenib:one case analysis
XU Fei-he1;SHEN Li-rong2

..............page:87-89

Preparation and in vivo-in vitro evaluation of docetaxel liposome for injection
WANG Dong-hai1;2;YANG Guang-li1;2;ZOU Wei-wei1;2;YAN Shou-sheng2;GONG Xin-jiang2;ZHOU Ying-lan2;YANG Qing-min1;2;WANG Jing-yi1;2

..............page:24-28

Cilostazol decreases the expression of ICAM-1 and VCAM-1 in the retina via up-regulating PPAR-γ in diabetic rats
HU Jian-ting1;2;WANG Ru-xia3;GAO Ling1

..............page:60-63

Determination of related impurities in the mycophenolate mofetil bulk drug by LC-ESI-FTICRMS/MS~n
WANG Peng-yuan;TONG Yuan-feng;ZHANG Jin-lan;WU Cai-sheng;WU Song

..............page:54-59,74

Improved synthetic method of lenalidomide
SONG Yan-ling1;JIANG Lu-lu1;WANG Xiao-huan2;MENG Yan-qiu1

..............page:75-78

Simultaneous determination of 3 components in Lianju Ganmao capsule by UPLC
HE Xun;CHI Ming-yan;WANG Ai-min;LAN Yan-yu;LI Yong-jun;WANG Yong-lin

..............page:79-82

Evaluation of plateau lip care balm in areas of Tibet at different altitudes:a multi-center and randomized phase Ⅱ trial
WANG Xiao-juan1;WANG Qin-tao2;DONG Guang-ying2;WANG Sheng-chao3;MA Zhi-wei2;WANG Rong1;GU Yi1;ZENG Ling-guang4;LI Hong-bo4;MA Ying-qian4;SONG Jiao4;CHEN Ying-hu4

..............page:50-53

Development in analytical methods for hirudin and recombinant hirudin
JIAO Jian1;JIANG Su-yun1;TANG Xin-qiang2;ZHANG Ting-ting1

..............page:33-35

Phase Ⅰ clinical trial for tolerance of Weikang tablet
GOU Zhong-ping;FENG Ping;LUO Zhu;ZOU Lin-ling

..............page:41-46

Proteomics analysis of isoniazid toxicity in rat liver
LIAO Yan2;PENG Shuang-qing1;ZHANG Li-shi3

..............page:18-23

Research advance in PEG-PLA block copolymers and its micro-or nano-particles as drug delivery system
ZHAO Gang;SU Qing;LI Jing;YU Sheng-hai

..............page:36-40

shen jing bing li xing teng tong zhi liao jin zhan zhuan lan

..............page:3-4

Current advance in clinical application of the β-adrenoceptor antagonist nebivolol
JIA Jing1;ZHANG Wei-hua2;LENG Xiao-ning1

..............page:5-9

WINDOW OF NEW DRUGS

..............page:1-2

Clinical evaluation of dexzopiclone in the treatment of type 2 diabetes mellitus accompanied by insomnia
WU Xue-yi;LIN Jin-hong

..............page:47-49

Molecular mechanisms of Jinyin granule effect on cholecystitis in guinea pigs
WANG Yu-chun;PANG Li-hong;TIAN Hua;LI Tao

..............page:64-67

Developments of the lipid emulsion used in the treatment of cardiac toxicity induced by bupivacaine
PENG Zhi-you;XUE Qing-sheng;FENG Xiao-mei;YU Bu-wei

..............page:29-32